NetworkNewsBreaks – Kaival Brands Innovations Gr
Post# of 402
Kaival Brands Innovations Group (KAVL), a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of small molecule protease inhibitors, has noted recent news from China outlining increased supervision over the e-cigarette category. KAVL, which is the exclusive global distributor of all products manufactured by Bidi Vapor LLC, welcomes the news, particularly as it pertains the BIDI(R) Stick disposable electronic nicotine delivery system (“ENDS”). The company noted that the expanding government regulations align with Kaival Brands’ dedicated and thorough efforts to maintain standards of compliance and quality. Kaival Brands and Bidi Vapor observed that the additional supervision of e-cigarette manufacturing should help raise standards for the devices worldwide. “Creating high-quality, viable alternatives for adult smokers aged 21 and over is a difficult and expensive task,” said Kaival Brands president and CEO Niraj Patel in the press release. “It’s not for the faint of heart, but for us, it’s a matter of integrity and our commitment to quality. . . . The Chinese government’s decisions will have no effect on Bidi Vapor or Kaival Brands and their respective operations, as each company has always been in full compliance with all U.S. requirements and regulations.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer